These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 35853660)

  • 21. Assessment of population infection with SARS-CoV-2 in Ontario, Canada, March to June 2020.
    Bolotin S; Tran V; Deeks SL; Peci A; Brown KA; Buchan SA; Ogbulafor K; Ramoutar T; Nguyen M; Thakkar R; DelaCruz R; Mustfa R; Maregmen J; Woods O; Krasna T; Cronin K; Osman S; Joh E; Allen VG
    Euro Surveill; 2021 Dec; 26(50):. PubMed ID: 34915969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SARS-CoV-2 vaccination, ABO blood group and risk of COVID-19: population-based cohort study.
    Ray JG; Park AL
    BMJ Open; 2022 Jul; 12(7):e059944. PubMed ID: 35851010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association Between ABO and Rh Blood Groups and SARS-CoV-2 Infection or Severe COVID-19 Illness : A Population-Based Cohort Study.
    Ray JG; Schull MJ; Vermeulen MJ; Park AL
    Ann Intern Med; 2021 Mar; 174(3):308-315. PubMed ID: 33226859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SARS-CoV-2 Testing and Complications Across 6 Waves of the COVID-19 Pandemic Among Individuals Recently Experiencing Homelessness in Ontario, Canada.
    Shariff SZ; Reid JN; Boozary AS; Booth R
    JAMA Netw Open; 2023 May; 6(5):e2312394. PubMed ID: 37155172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COVID-19 Case Age Distribution: Correction for Differential Testing by Age.
    Fisman DN; Greer AL; Brankston G; Hillmer M; O'Brien SF; Drews SJ; Tuite AR
    Ann Intern Med; 2021 Oct; 174(10):1430-1438. PubMed ID: 34399059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SARS-CoV-2 antibodies in Ontario health care workers during and after the first wave of the pandemic: a cohort study.
    Science M; Bolotin S; Silverman M; Nadarajah J; Maguire B; Parekh RS; McGeer A; Schwartz KL; Alexander L; Allen U; Ariyarajah A; Castellani L; Cohn RD; Downing M; Katz K; Kazmi K; Leis JA; Liu D; Pernica JM; Schneiderman JE; Sumaida M; Campigotto A
    CMAJ Open; 2021; 9(4):E929-E939. PubMed ID: 34642255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modelling resource requirements and physician staffing to provide virtual urgent medical care for residents of long-term care homes: a cross-sectional study.
    Razak F; Shin S; Pogacar F; Jung HY; Pus L; Moser A; Lapointe-Shaw L; Tang T; Kwan JL; Weinerman A; Rawal S; Kushnir V; Mak D; Martin D; Shojania KG; Bhatia S; Agarwal P; Mukerji G; Fralick M; Kapral MK; Morgan M; Wong B; Chan TCY; Verma AA
    CMAJ Open; 2020; 8(3):E514-E521. PubMed ID: 32819964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Household transmission of SARS-CoV-2 from unvaccinated asymptomatic and symptomatic household members with confirmed SARS-CoV-2 infection: an antibody-surveillance study.
    Bhatt M; Plint AC; Tang K; Malley R; Huy AP; McGahern C; Dawson J; Pelchat M; Dawson L; Varshney T; Arnold C; Galipeau Y; Austin M; Thampi N; Alnaji F; Langlois MA; Zemek RL
    CMAJ Open; 2022; 10(2):E357-E366. PubMed ID: 35414597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High prevalence of SARS-CoV-2 infection among symptomatic healthcare workers in a large university tertiary hospital in São Paulo, Brazil.
    Buonafine CP; Paiatto BNM; Leal FB; de Matos SF; de Morais CO; Guerra GG; Martuchelli MVV; Oliveira DBL; Durigon EL; Soares CP; Candido ED; Telezynski BL; Sáfadi MAP; Almeida FJ
    BMC Infect Dis; 2020 Dec; 20(1):917. PubMed ID: 33267836
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early trends for SARS-CoV-2 infection in central and north Texas and impact on other circulating respiratory viruses.
    Mutnal MB; Arroliga AC; Walker K; Mohammad A; Brigmon MM; Beaver RM; Midturi JK; Rao A
    J Med Virol; 2020 Oct; 92(10):2130-2138. PubMed ID: 32410236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Seroprevalence of Unidentified SARS-CoV-2 Infection in Hong Kong During 3 Pandemic Waves.
    Boon SS; Wong MCS; Ng RWY; Leung DTM; Chen Z; Lai CKC; Ho WCS; Huang J; Wong BKC; Fung KSC; Chan PKS
    JAMA Netw Open; 2021 Nov; 4(11):e2132923. PubMed ID: 34779848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systematic on-site testing for SARS-CoV-2 infection among asymptomatic essential workers in Montréal, Canada: a prospective observational and cost-assessment study.
    Campbell JR; Dion C; Uppal A; Yansouni CP; Menzies D
    CMAJ Open; 2022; 10(2):E409-E419. PubMed ID: 35537749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Seropositivity and risk factors for SARS-CoV-2 infection in a South Asian community in Ontario: a cross-sectional analysis of a prospective cohort study.
    Anand SS; Arnold C; Bangdiwala SI; Bolotin S; Bowdish D; Chanchlani R; de Souza RJ; Desai D; Kandasamy S; Khan F; Khan Z; Langlois MA; Limbachia J; Lear SA; Loeb M; Loh L; Manoharan B; Nakka K; Pelchat M; Punthakee Z; Schulze KM; Williams N; Wahi G
    CMAJ Open; 2022; 10(3):E599-E609. PubMed ID: 35790229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantifying the magnitude of the general contextual effect in a multilevel study of SARS-CoV-2 infection in Ontario, Canada: application of the median rate ratio in population health research.
    Watson T; Kwong JC; Kornas K; Mishra S; Rosella LC
    Popul Health Metr; 2024 Oct; 22(1):27. PubMed ID: 39375666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical risk, sociodemographic factors, and SARS-CoV-2 infection over time in Ontario, Canada.
    Udell JA; Behrouzi B; Sivaswamy A; Chu A; Ferreira-Legere LE; Fang J; Goodman SG; Ezekowitz JA; Bainey KR; van Diepen S; Kaul P; McAlister FA; Bogoch II; Jackevicius CA; Abdel-Qadir H; Wijeysundera HC; Ko DT; Austin PC; Lee DS
    Sci Rep; 2022 Jun; 12(1):10534. PubMed ID: 35750706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of the COVID-19 pandemic on the provision of routine childhood immunizations in Ontario, Canada.
    Piché-Renaud PP; Ji C; Farrar DS; Friedman JN; Science M; Kitai I; Burey S; Feldman M; Morris SK
    Vaccine; 2021 Jul; 39(31):4373-4382. PubMed ID: 34108076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Derivation and Internal Validation of a Model to Predict the Probability of Severe Acute Respiratory Syndrome Coronavirus-2 Infection in Community People.
    van Walraven C; Manuel DG; Desjardins M; Forster AJ
    J Gen Intern Med; 2021 Jan; 36(1):162-169. PubMed ID: 33107007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mass testing after a single suspected or confirmed case of COVID-19 in London care homes, April-May 2020: implications for policy and practice.
    Tang S; Sanchez Perez M; Saavedra-Campos M; Paranthaman K; Myers R; Fok J; Crawley-Boevey E; Dun-Campbell K; Janarthanan R; Fernandez E; Vusirikala A; Patel B; Ma T; Amin-Chowdhury Z; Shetty N; Zambon M; Bell A; Wynne-Evans E; Chow Y; Ladhani S
    Age Ageing; 2021 May; 50(3):649-656. PubMed ID: 33620453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outbreak of SARS-CoV-2 infection at a large refugee shelter in Toronto, April 2020: a clinical and epidemiologic descriptive analysis.
    Redditt V; Wright V; Rashid M; Male R; Bogoch I
    CMAJ Open; 2020; 8(4):E819-E824. PubMed ID: 33293331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mortality and critical care unit admission associated with the SARS-CoV-2 lineage B.1.1.7 in England: an observational cohort study.
    Patone M; Thomas K; Hatch R; Tan PS; Coupland C; Liao W; Mouncey P; Harrison D; Rowan K; Horby P; Watkinson P; Hippisley-Cox J
    Lancet Infect Dis; 2021 Nov; 21(11):1518-1528. PubMed ID: 34171232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.